1-Year Follow up to the 1473-IMIQ Study

Completed

Conditions studied: Keratosis

In brief

This is a 1-year follow-up study to evaluate the long-term effects in subjects who completely cleared their actinic keratosis (AK) lesions in the 1473-IMIQ study. The 1473-IMIQ study evaluated the safety and effectiveness of imiquimod 5% cream compared to a placebo cream for the treatment of AK.

Key facts

Study ID

NCT00114023

Run by

Graceway Pharmaceuticals, LLC

People needed

84

Starts

2005-01-01

Last updated by the study team

2007-02-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subject had to participate in the 1473-IMIQ Study AND have had 100% clearance of AK lesions

You may not qualify if…

• Did not use any topical preparations in the previous treatment area within 24-hours of the scheduled visit.

Where it is running

• Study site — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.